Method
Live-Online
Term
WINTER
Units
1.5 QUARTER UNITS
Cost
$625

Course Description

This course presents the essential elements of monitoring a clinical trial and the interaction between a sponsor and one or more sites during a clinical investigation. The course covers expectations of the FDA, the sponsor, and the site. The process of site selection, budgeting, initiation visits, source documentation, regulatory documentation, and adverse event reporting are additional topics covered. Included in the course are the process of medical record review and maintenance, case report form completion, product accountability, and various tasks associated with different monitoring visits.

Learning Outcomes

At the conclusion of the course, you should be able to

  • Explain the regulatory requirements of monitoring a clinical study site.
  • Explain the roles and responsibilities of sponsors, CROs, and study sites during monitoring visits.
  • Plan and execute monitoring visits before, during, and after site visits.
  • Complete monitoring visit reports.
  • Track key issues involved in monitoring a clinical study site, including source data verification, data integrity, and TMF/ISF inspection readiness.

 

Professional Credit: CA BRN/LVN Credit--Provider #CEP13114.

*This course may be applied to a certificate only if you are currently declared in a program.

 

Prerequisites / Skills Needed

Prerequisites:

  • CTDM.X411: Good Clinical Practices
  • Live-Online Attend via Zoom at scheduled times.
Schedule
Date Start Time End Time Meeting Type Location
Tue, 01-12-2027 6:00pm 9:00pm Live-Online REMOTE
Tue, 01-19-2027 6:00pm 9:00pm Live-Online REMOTE
Tue, 01-26-2027 6:00pm 9:00pm Live-Online REMOTE
Tue, 02-02-2027 6:00pm 9:00pm Live-Online REMOTE
Tue, 02-09-2027 6:00pm 9:00pm Live-Online REMOTE
 

This class is offered in an online synchronous format. Students are expected to log into this course via Canvas at the start time of scheduled meetings and participate via Zoom, for the duration of each scheduled class meeting.

To see all meeting dates, click "Full Schedule" below.

You will be granted access in Canvas to your course site and course materials approximately 24 hours prior to the published start date of the course.

Required Tools & Materials:

ICH E6(R3) guideline, 21 CFR Parts 50/54/56/312, FDA Guidance "Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring" (2013)  
This will be provided via Canvas by the instructor.   
 

||

Prerequisites / Skills Needed

Prerequisites:

  • CTDM.X411: Good Clinical Practices

This course applies to these programs:

Demo